South Korea Polymyositis Market Size & Outlook, 2026-2034


South Korea Polymyositis Market Insights

  • As highlighted in Reed Intelligence analysis, the South Korea Polymyositis Market, worth USD 10.56 Million in 2025, is forecasted to achieve USD 19.07 Million by 2034.
  • The South Korea market is anticipated to grow at a CAGR of 6.73% during the period 2026–2034.
  • By 2025, Corticosteroids represented the largest share of the Treatment Type market size.
  • Biologics is expected to remain the key growth driver within Treatment Type, registering the fastest CAGR during the forecast period.

Other Key Findings


  • South Korea contributed 0.83% to the global Polymyositis Market size in 2025.
  • By 2034, United States is forecasted to remain the largest global market for Polymyositis Market.
  • In Asia Pacific, China is projected to capture the leading share of market size by 2034.
  • Among Asia Pacific markets, Japan is expected to post the fastest growth, reaching USD 49.22 Million by 2034.

Report Summary

Report Scope Details
Base Year for Study 2025
Study Period 2022-2034
Historical Period 2022-2024
Forecast Period 2026-2034
Market Size In 2025 USD 10.56 Million
Market Size In 2034 USD 19.07 Million
Largest segment Corticosteroids
Units Revenue in USD Million
CAGR 6.73% (2026-2034)
Segmnetation Covered
Treatment Type
  1. Corticosteroids
  2. Immunosuppressants
  3. Biologics
  4. Others
Diagnosis Method
  1. Blood Tests
  2. Imaging Techniques
  3. Muscle Biopsy
  4. Electromyography
End-Use
  1. Hospitals
  2. Specialty Clinics
  3. Research Institutes
  4. Others
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends